Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO B | DKK 738.10 | -2.4% | 5.1% | DKK 3.3t | DKK 938.04 | PE34.5x | E14.4% | 1.3% | Pharmaceuticals & Biotech | ||
NETC New | DKK 347.00 | 3.0% | 48.7% | DKK 16.6b | DKK 340.29 | PE39.7x | E30.0% | 0% | Software | ||
ALK B New | DKK 156.70 | -1.9% | 67.5% | DKK 34.7b | DKK 181.20 | PE44.2x | E21.5% | 0% | Pharmaceuticals & Biotech |